News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS) Chairman Stresses Need For R&D Investment


3/24/2014 7:53:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Novartis AG needs to continue investing in research to develop new drugs that national health-care systems are willing to pay for, a task that gets harder as generic versions of older medicines become available, the company's chairman said. Joerg Reinhardt, who assumed his role in August, says the benchmark for evaluating drugs is constantly rising as branded medicines lose patent protection, allowing for less-expensive copies to enter the market.

Help employers find you! Check out all the jobs and post your resume.

Read more at The Wall Street Journal

comments powered by Disqus


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES